Trial intelligence / Profile preview

Intrathecal nalbuphine in bilateral total knee arthroplasty

TCTR20250623002Phase 2Not yet recruiting

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Start
Jul 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nalbuphine in postoperative pain, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

nalbuphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on TCTR20250623002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250623002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call